TrialAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.

Xiaowei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.